Plasma therapy is one of several different experimental longevity procedures that involve blood transfers, including platelet ...

Following FDA approval of Imaavy, we explore promising biotech candidates in development for myasthenia gravis.

R&D spending across the global pharmaceutical sector climbed 1.5% in 2024, according to unreleased data from Evaluate Pharma.

Shuttle-based therapies are under active development for an array of brain conditions. “It’s now abundantly clear that we can ...

The Federal Court has granted Alexion a declaration of infringement and an injunction preventing Amgen from manufacturing, ...

A new antivenom relies on antibodies from the blood of Tim Friede, who immunized himself against snakebites by injecting increasing doses of venom into his body.

At last, the stage was set for lifesaving blood transfusions. No more lambs’ or calves’ blood; no more transfusions from whoever happens to be in the room at the time – science now knew that humans ...

A man’s acquired hemophilia coincided with a rare liver disease, a connection that had not been reported before, per a case ...

COVID-19 testing includes molecular (PCR), antigen (rapid), and antibody (serology) tests, each serving different ...

The human organism is far too complex and unpredictable to program like a computer and optimize for longevity.

At the intersection of a red meat allergy and a cancer-drug reaction investigations, researchers pinned a lone star culprit.